CME (CME) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About CME
CME is led by CEO Terrence A. Duffy, employs 3,760 people, headquartered in Chicago, US, publicly traded since 2002.
CME stock trades at $277.77 with a market capitalization of $99.88B. The stock is valued at a price-to-earnings (P/E) ratio of 24.12, price-to-book of 3.88, price-to-sales of 15.17. Over the past 52 weeks the stock has ranged between $218.31 and $329.16, and currently trades 15.6% below its 52-week high. It pays a dividend yielding 1.82%.
On profitability, CME generates a return on equity (ROE) of 15.53%, above the typical market average, return on capital employed of 12.28%, an operating margin of 65.57%, a net profit margin of 63.08%.
In its most recent fiscal year, CME reported annual revenue of $6.5B, net profit of $4.0B, revenue has compounded at 6.0% a year over the last five years, profit at 13.9% a year. Profit growing faster than revenue points to expanding margins.
The balance sheet shows a debt-to-equity ratio of 0.13 — a conservative balance sheet with little leverage risk, a current ratio of 92.64, total assets of $198.5B, $4.4B in cash and equivalents.
CME has a beta of 0.27 (less volatile than the overall market).